BIOMAT Database Logo BIOMAT Database Logo

[Use of prodigiozan in the combined therapy of infectious diseases (a review of the literature)]. 1986

V M Frolov, and V E Rychnev

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D011135 Polysaccharides, Bacterial Polysaccharides found in bacteria and in capsules thereof. Bacterial Polysaccharides
D011354 Prodigiozan A polysaccharide extracted from Serratia marcescens and other bacteria. It activates enzymatic activity of macrophages and stimulates phagocytic processes. Prodigiosan
D002463 Cell Membrane Permeability A quality of cell membranes which permits the passage of solvents and solutes into and out of cells. Permeability, Cell Membrane
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003141 Communicable Diseases An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host. Infectious Diseases,Communicable Disease,Disease, Communicable,Disease, Infectious,Diseases, Communicable,Diseases, Infectious,Infectious Disease
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

V M Frolov, and V E Rychnev
[Combined therapy of inflammatory diseases of the female genitalia with prodigiozan].
February 1971, Antibiotiki,
V M Frolov, and V E Rychnev
Hyponatremia in Infectious Diseases-A Literature Review.
July 2020, International journal of environmental research and public health,
V M Frolov, and V E Rychnev
Levamisole in infectious diseases--a review of the literature.
January 1978, The Journal of rheumatology. Supplement,
V M Frolov, and V E Rychnev
[Use of pyrogenal in the overall treatment of infectious diseases (a review of the literature)].
February 1980, Vrachebnoe delo,
V M Frolov, and V E Rychnev
[The use of prodigiozan in the combined therapy of the sequelae of mild craniocerebral trauma].
July 1999, Likars'ka sprava,
V M Frolov, and V E Rychnev
[Use of prodigiozan in chronic diseases of intestine].
February 1969, Antibiotiki,
V M Frolov, and V E Rychnev
[Psychiatric aspects of infectious diseases -- a literature review].
December 2014, Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology,
V M Frolov, and V E Rychnev
[Hyperbaric oxygenation in the combined therapy of infectious diseases].
January 1992, Klinicheskaia meditsina,
V M Frolov, and V E Rychnev
[Use of prodigiozan in the complex therapy of dysentery].
April 1973, Vrachebnoe delo,
V M Frolov, and V E Rychnev
[Use of prodigiozan in the complex therapy of burns].
January 1971, Antibiotiki,
Copied contents to your clipboard!